Published in Surg Radiol Anat on August 13, 2010
Visualisation of the Bonebridge by means of CT and CBCT. Eur J Med Res (2013) 0.96
Artifacts of the electrode in cochlea implantation and limits in analysis of deep insertion in cone beam tomography (CBT). Eur Arch Otorhinolaryngol (2011) 0.90
Presentation of floating mass transducer and Vibroplasty couplers on CT and cone beam CT. Eur Arch Otorhinolaryngol (2013) 0.83
Use of cone beam computed tomography in the diagnosis of superior semicircular canal dehiscence. J Clin Imaging Sci (2014) 0.75
Visualisation of passive middle ear implants by cone beam and multi-detector computed tomography: a comparative in vitro study. Eur Radiol (2016) 0.75
Visualization of anatomy in normal and pathologic middle ears by cone beam CT. Eur Arch Otorhinolaryngol (2016) 0.75
Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46
Development of a compact computed tomographic apparatus for dental use. Dentomaxillofac Radiol (1999) 2.79
Conebeam CT of the head and neck, part 1: physical principles. AJNR Am J Neuroradiol (2009) 1.78
Limited cone-beam computed tomography imaging of the middle ear: a comparison with multislice helical computed tomography. Acta Radiol (2007) 1.66
Analysis of clustered matched-pair data. Stat Med (2003) 1.46
Assessment of bone segmentation quality of cone-beam CT versus multislice spiral CT: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.45
A comparison of a new limited cone beam computed tomography machine for dental use with a multidetector row helical CT machine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 1.44
Calculating effective dose on a cone beam computed tomography device: 3D Accuitomo and 3D Accuitomo FPD. Dentomaxillofac Radiol (2008) 1.23
Cone beam computed tomography, a low-dose imaging technique in the postoperative assessment of cochlear implantation. Otol Neurotol (2009) 1.05
Experimental flat-panel high-spatial-resolution volume CT of the temporal bone. AJNR Am J Neuroradiol (2004) 0.99
Cone-beam computed tomography: a new method for imaging of the temporal bone. Acta Radiol (2009) 0.91
Imaging procedures in cochlear implant patients--evaluation of different radiological techniques. Acta Otolaryngol Suppl (2004) 0.90
Advances in skull base imaging. Otolaryngol Clin North Am (2007) 0.90
Digital volume tomography: radiologic examinations of the temporal bone. AJR Am J Roentgenol (2006) 0.88
Three-dimensional images of the reuniting duct using cone beam CT. Acta Otolaryngol (2009) 0.87
Oblique multiplanar reformation in multislice temporal bone CT. Surg Radiol Anat (2009) 0.86
A new cone beam computerized tomography system for use in endodontic surgery. Int Endod J (2007) 0.84
Value of digital volume tomography in patients with conductive hearing loss. Eur Arch Otorhinolaryngol (2005) 0.84
High-resolution flat-panel volume-CT of temporal bone--part 1: axial preoperative anatomy. J Comput Assist Tomogr (2005) 0.80
[Imaging of the temporal bone. An overview]. Radiologe (2005) 0.77
Three-dimensional CT-imaging of the ossicular chain. Clin Otolaryngol Allied Sci (1995) 0.76
Rotational tomography in cochlear implant patients: a new tool for quality control of the electrode position. Cochlear Implants Int (2004) 0.75
The technique of direct multiplanar high resolution CT of the temporal bone. Neurosurg Rev (1985) 0.75
Analysis of pneumatization and neurovascular structures of the sphenoid sinus using cone-beam tomography (CBT). Acta Radiol (2012) 2.19
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer (2008) 1.51
Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol (2004) 1.42
Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39
Pathogenesis of lymphangiomas. Virchows Arch (2008) 1.35
Which tinnitus patients benefit from transcranial magnetic stimulation? Otolaryngol Head Neck Surg (2007) 1.29
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review. Head Neck (2010) 1.20
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol (2011) 1.14
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13
Cutaneous manifestation of myiasis in malignant wounds of the head and neck. Eur J Dermatol (2008) 1.12
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Parathyroid carcinoma: a review. Head Neck (2011) 1.02
Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res (2011) 1.01
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2012) 1.00
Chronic sclerosing sialadenitis of the submandibular gland is mainly due to a T lymphocyte immune reaction. Mod Pathol (2002) 1.00
The value of digital volume tomography in assessing the position of cochlear implant arrays in temporal bone specimens. Ear Hear (2010) 0.97
Sclerotherapy of lymphangiomas of the head and neck. Head Neck (2010) 0.96
Analysis of the fossa olfactoria using cone beam tomography (CBT). Acta Otolaryngol (2010) 0.96
Evolution of the management of laryngeal cancer. Oral Oncol (2006) 0.96
Intralesional endoscopy of advanced lymphatic malformations of the head and neck: a new diagnostic approach and a potential therapeutic tool. Arch Otolaryngol Head Neck Surg (2010) 0.96
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol (2008) 0.94
Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck (2010) 0.93
Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor. FEBS Lett (2006) 0.92
Management of vascular malformations and hemangiomas of the head and neck--an update. Curr Opin Otolaryngol Head Neck Surg (2013) 0.91
Digital volume tomography (DVT) as a diagnostic modality of the anterior skull base. Acta Otolaryngol (2009) 0.90
Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease. Rhinology (2005) 0.90
MMP-2 expression in 102 patients with glottic laryngeal cancer. Eur Arch Otorhinolaryngol (2011) 0.90
Novel approach to complex pulmonary arteriovenous malformation embolization using detachable coils and Amplatzer vascular plugs. Eur J Radiol (2012) 0.90
Post-tonsillectomy hemorrhage--some facts will never change. Eur Arch Otorhinolaryngol (2014) 0.90
Treatment of benign tracheal stenosis utilizing self-expanding nitinol stents. Cardiovasc Intervent Radiol (2004) 0.89
Early side effects after embolization of a carotid body tumor using Onyx. J Vasc Surg (2010) 0.89
Transcervical extirpation of the submandibular gland: the University of Marburg experience. Eur Arch Otorhinolaryngol (2013) 0.88
Understanding contraindications for transoral robotic surgery (TORS) for oropharyngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.88
Digital volume tomography: radiologic examinations of the temporal bone. AJR Am J Roentgenol (2006) 0.88
Balloon sinuplasty: a current hot topic in rhinology. Eur Arch Otorhinolaryngol (2008) 0.88
What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010? Eur Arch Otorhinolaryngol (2010) 0.88
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncol (2009) 0.87
Bacteria and pathogenesis of human salivary calculus. Acta Otolaryngol (2002) 0.87
Postoperative morbidity after different types of selective neck dissection. Laryngoscope (2010) 0.87
Treatment considerations for head and neck cancer in the elderly. J Laryngol Otol (2005) 0.86
Digital volume tomography (DVT) measurements of the olfactory cleft and olfactory fossa. Acta Otolaryngol (2010) 0.86
Implications of a positive sentinel node in oral squamous cell carcinoma. Head Neck (2012) 0.85
Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer. Anticancer Res (2007) 0.85
Head and neck cancer in the elderly: a cohort study in 40 patients. Acta Oncol (2005) 0.85
Expression of galectin-3 in adenoid cystic carcinoma of the head and neck and its relationship with distant metastasis. J Cancer Res Clin Oncol (2005) 0.84
Incidence of sinunasal disease in laryngectomized patients. ORL J Otorhinolaryngol Relat Spec (2008) 0.84
Pharmacotherapy for squamous-cell carcinoma of the head and neck. Expert Opin Pharmacother (2011) 0.84
Block copolymer carrier systems for translymphatic chemotherapy of lymph node metastases. Anticancer Res (2008) 0.83
Extracervical approaches to endoscopic thyroid surgery. Surg Endosc (2010) 0.83
Evaluation of the tolerance and distribution of intravenously applied ferrofluid particles of 250 and 500 nm size in an animal model. J Drug Target (2009) 0.83
Management of mandibular invasion: when is a marginal mandibulectomy appropriate? Oral Oncol (2005) 0.83
Central compartment dissection in laryngeal cancer. Head Neck (2010) 0.82
Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia -- analysis of distribution and symptoms. Eur J Dermatol (2004) 0.82
Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer (2005) 0.82
Localization and treatment of lingual venous and arteriovenous malformations. Vasc Med (2014) 0.82
Polysomnography outcomes following transoral CO2 laser microsurgery in pediatric patients with laryngomalacia. Int J Pediatr Otorhinolaryngol (2009) 0.82
Endonasal endoscopic medial maxillectomy with preservation of the inferior turbinate. Am J Rhinol Allergy (2010) 0.81
Chronic sclerosing sialadenitis of the submandibular gland is not just a severe chronic sialadenitis. Am J Otolaryngol (2003) 0.81
Head and neck cancer surgery in the elderly: outcome evaluation with the McPeek score. Ann Otol Rhinol Laryngol (2011) 0.81
Is Warthin's tumour of the parotid gland a lymph node disease? Histopathology (2011) 0.81
Epidermal growth factor-induced modulation of cytokeratin expression levels influences the morphological phenotype of head and neck squamous cell carcinoma cells. Cell Tissue Res (2012) 0.81
Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53. Clin Cancer Res (2005) 0.81
Experiences with a new surgical technique for closure of large perforations of the nasal septum in 55 patients. Am J Rhinol Allergy (2011) 0.81
Value of endotracheal tube safety in laryngeal laser surgery. Lasers Surg Med (2003) 0.80
Laser treatment of mucosal venous malformations of the upper aerodigestive tract in 50 patients. Lasers Med Sci (2010) 0.80
The auricular VX2 carcinoma: feasibility of complete tumor resection. Anticancer Res (2005) 0.80
Differential expression of VEGF121, VEGF165 and VEGF189 in angiomas and squamous cell carcinoma cell lines of the head and neck. Anticancer Res (2010) 0.80
End-of-life care for terminal head and neck cancer patients. Cancer Nurs (2008) 0.80
Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol (2006) 0.80
Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy. Anticancer Res (2003) 0.80
Delphian node metastasis in head and neck cancers--oracle or myth? J Surg Oncol (2010) 0.80
The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas. Oral Oncol (2009) 0.80
Acute haemorrhage in patients with advanced head and neck cancer: value of endovascular therapy as palliative treatment option. J Laryngol Otol (2005) 0.80
Laser surgical treatment of laryngeal paraganglioma. J Laryngol Otol (2003) 0.80
Orbital and periorbital vascular anomalies--an approach to diagnosis and therapeutic concepts. Acta Otolaryngol (2010) 0.80
A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. J Cancer Res Clin Oncol (2014) 0.80
Transforming growth factor beta in chronic obstructive sialadenitis of human submandibular gland. Arch Oral Biol (2003) 0.80
Melanomas of unknown primary frequently harbor TERT-promoter mutations. Melanoma Res (2014) 0.80
Analysis of cytokine levels in human lymphangiomas. In Vivo (2008) 0.80
A clinical study of the efferent auditory system in patients with normal hearing who have acute tinnitus. Otol Neurotol (2007) 0.80
Lymph node metastasis in an animal model: effect of piecemeal laser surgical resection. Lasers Surg Med (2005) 0.79
Scintigraphic assessment of salivary gland function in a rat model. In Vivo (2010) 0.79
The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol (2003) 0.79
Jewelry-induced diseases of the head and neck. Ann Plast Surg (2002) 0.79
Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol (2005) 0.79
Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Am J Rhinol (2005) 0.79
Lymphatic malformations of the orbit. Clin Exp Otorhinolaryngol (2013) 0.78
EGFR codon 497 polymorphism - implications for receptor sensitivity to inhibitors in HNSCC cell lines. Anticancer Res (2011) 0.78